E-Newsletter - November 2015

Deadlines for Upcoming Alliance Abstracts

Abstract Review Process Reminders

  • All draft abstracts from the Alliance for Clinical Trials in Oncology must be submitted to Publications@AllianceNCTN.org for Alliance Group Review. Independent submission of work related to the Alliance without this proper review is not appropriate. 
  • All known, upcoming deadlines through December are noted below.
  • These deadlines are firm, and are required to ensure time for central review of content, as well as review of author lists.
  • Adherence to this schedule will assure sufficient time for the each lead investigator to submit to these symposiums and conferences.

Abstract Content Requirements

An Alliance abstract should contain the following information:

  • Study number(s)
    • For an Alliance study X, the study number should appear in the title as “Alliance X”
    • For a legacy study, the study number should appear in the title as “[Legacy Group Name] X (Alliance)” (e.g., “CALGB 40101 (Alliance)”)
    • If multiple studies are involved and the title cannot accommodate all of the numbers, the study numbers must appear in the text of the abstract.
  • Authors
    • The Alliance statistician must appear in the list of authors, usually as second author
    • Authorship based on accrual is assigned by the publications coordinator according to algorithms in the Alliance Publications Guidelines, and will be communicated to the first author after receipt of the abstract for Group Review.
    • Provide the institutional affiliation, city, and state for each author. Affiliations for Alliance Statisticians should include “Alliance Statistics and Data Center” followed by their institution, city, and state.
    • Provide the name and contact information of the corresponding author.

Accepted Abstracts

Please send the publications coordinator the acceptance notification and final accepted abstract within one (1) week after hearing from meeting or association. Note: If the meeting sponsor requires the authors to submit a manuscript by the time of the meeting or another specified date, it is authors’ responsibility to notify us promptly of this obligation and make arrangements to ensure we can accommodate a timely review.

Remaining 2015 Deadline Dates


*  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *

For other articles in the November issue of the Alliance E-News newsletter, see below.